Clinical Trials Browser

INDUSTRY × Neoplasms × poly ICLC × Clear all

NCT06614140 2024-09-26

Personalized Neoantigen Cancer Vaccine for Patients with Solid Tumors

Phase 1/2 Active not recruiting

Neoplasms

NCT02423863 2020-12-17

Poly-ICLC

Phase 2 Completed

DermatologicHead & NeckSarcoma

Head and Neck Neoplasms, Melanoma, Neoplasms, Sarcoma